Pulmonary Copper Oxide Nanoparticles Induce Systemic Prothrombotic State and Oxidative Stress in Mice
Background
Copper oxide nanoparticles (CuONPs) are increasingly utilized across various industrial and biomedical sectors, yet their comprehensive safety profile, particularly regarding systemic vascular and hemostatic disturbances, remains largely undefined. A critical gap exists in understanding how pulmonary exposure to these nanoparticles might translate into broader physiological impacts. Uncontrolled inflammation and oxidative stress are known drivers of vascular dysfunction and prothrombotic states, making it crucial to investigate if CuONPs can initiate these detrimental cascades systemically following inhalation.
Study Design
BALB/c mice were subjected to a single pulmonary instillation of CuONPs at doses of 3 µg or 30 µg per mouse. Endpoints were evaluated 24 hours post-exposure. Prior to biological testing, the CuONPs underwent characterization via X-ray diffraction, dynamic light scattering, zeta potential analyses, and transmission electron microscopy to confirm their physical properties. The study assessed thrombotic occlusion times, coagulation parameters, plasma inflammatory markers, oxidative stress indicators, and markers of DNA damage and apoptosis.
Results
Pulmonary CuONP exposure significantly altered hemostatic balance, shortening thrombotic occlusion times in both arterioles and venules. Coagulation times were also affected, with reduced prothrombin and activated partial thromboplastin times. Systemic inflammation was evident through elevated plasma levels of platelet factor 4, fibrinogen, plasminogen activator inhibitor-1, and C-reactive protein. Oxidative stress markers were significantly increased, including thiobarbituric acid-reactive substances, alongside depleted glutathione levels and decreased nitric oxide levels. Pro-inflammatory cytokines were also upregulated.
CuONPs induced significant upregulation of pro-inflammatory cytokines, including
tumor necrosis factor-α,interleukin (IL)-6, andIL-1β, alongside markers of DNA damage and apoptosis such as8-hydroxy-2'-deoxyguanosine,cytochrome Crelease, andcleaved caspase-3expression.
Key Findings
- Pulmonary CuONP exposure significantly shortened thrombotic occlusion times in arterioles and venules.
- CuONPs reduced prothrombin and activated partial thromboplastin times, indicating a prothrombotic shift.
- Plasma levels of platelet factor 4, fibrinogen, plasminogen activator inhibitor-1, and C-reactive protein were elevated.
- Oxidative stress markers (TBARS) increased, while glutathione and nitric oxide levels decreased.
- Pro-inflammatory cytokines (
TNF-α,IL-6,IL-1β) and DNA damage markers (8-hydroxy-2'-deoxyguanosine,cleaved caspase-3) were upregulated.
Why It Matters
This study provides critical insights into the systemic risks associated with pulmonary exposure to copper oxide nanoparticles, highlighting that even acute exposure can trigger a cascade of adverse events. For individuals in industrial settings or those exposed to CuONPs in environmental contexts, these findings underscore a potential for increased vascular risk, including prothrombotic states and systemic inflammation. While not directly applicable to peptide users, this research emphasizes the broader need for rigorous safety evaluations of novel materials, especially those with increasing environmental or biomedical presence. It suggests that protocols involving CuONPs, even for localized applications, should consider potential systemic ramifications.
copper oxide nanoparticles
cuonps
pulmonary exposure
systemic inflammation
oxidative stress
prothrombotic